" class="no-js "lang="en-US">
Home » People » Ken Takeshita
October 4 2021
The Food and Drug Administration (FDA) has granted Enhertu (trastuzumab deruxtecan), Breakthrough Therapy Designation (BTD) in the […]
Join Our Newsletter.
Subscribe to receive email updates from Medtech Alert.